Literature DB >> 22364720

Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Patrick S Connell1, Richard I Han, K Jane Grande-Allen.   

Abstract

During the course of both canine and human aging, the mitral valve remodels in generally predictable ways. The connection between these aging changes and the morbidity and mortality that accompany pathologic conditions has not been made clear. By exploring work that has investigated the specific valvular changes in both age and disease, with respect to the cells and the extracellular matrix found within the mitral valve, heretofore unexplored connections between age and myxomatous valve disease can be found. This review addresses several studies that have been conducted to explore such age and disease related changes in extracellular matrix, valvular endothelial and interstitial cells, and valve innervation, and also reviews attempts to correlate aging and myxomatous disease. Such connections can highlight avenues for future research and help provide insight as to when an individual diverts from an aging pattern into a diseased pathway. Recognizing these patterns and opportunities could result in earlier intervention and the hope of reduced morbidity and mortality for patients. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22364720      PMCID: PMC3307912          DOI: 10.1016/j.jvc.2011.11.003

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  110 in total

Review 1.  Anatomy of the mitral valve.

Authors:  S Y Ho
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  The anatomy of the canine mitral valve, with notes on function and comparisons with other mammalian mitral valves.

Authors:  R W FRATER; F H ELLIS
Journal:  J Surg Res       Date:  1961-09       Impact factor: 2.192

3.  Scanning electron microscopy of operatively excised severely regurgitant floppy mitral valves.

Authors:  P D Stein; C H Wang; J M Riddle; H N Sabbah; D J Magilligan; E T Hawkins
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

4.  Anatomy of human mitral valve in adult cadaver and comparative anatomy of the valve.

Authors:  R Walmsley
Journal:  Br Heart J       Date:  1978-04

Review 5.  Molecular regulation of atrioventricular valvuloseptal morphogenesis.

Authors:  L M Eisenberg; R R Markwald
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

6.  Phenotypic characterization of isolated valvular interstitial cell subpopulations.

Authors:  Tracy L Blevins; Joshua L Carroll; Alina M Raza; K Jane Grande-Allen
Journal:  J Heart Valve Dis       Date:  2006-11

7.  Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.

Authors:  H Aupperle; J Thielebein; B Kiefer; I März; G Dinges; H-A Schoon; A Schubert
Journal:  J Comp Pathol       Date:  2009-03-12       Impact factor: 1.311

8.  Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse.

Authors:  Hsiang-Tai Chou; Yi-Ru Shi; Yuan Hsu; Fuu-Jen Tsai
Journal:  J Heart Valve Dis       Date:  2003-07

Review 9.  The genetics of mitral valve prolapse.

Authors:  J B Grau; L Pirelli; P-J Yu; A C Galloway; H Ostrer
Journal:  Clin Genet       Date:  2007-10       Impact factor: 4.438

10.  Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.

Authors:  Sirilak Disatian; E J Ehrhart; Sarah Zimmerman; E Christopher Orton
Journal:  J Heart Valve Dis       Date:  2008-07
View more
  7 in total

Review 1.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

2.  Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice.

Authors:  Kondapalli Mrudula Spurthi; Mohsen Sarikhani; Sneha Mishra; Perumal Arumugam Desingu; Shikha Yadav; Swathi Rao; Sangeeta Maity; Ankit Kumar Tamta; Shweta Kumar; Shamik Majumdar; Aditi Jain; Aishwarya Raghuraman; Danish Khan; Ishwar Singh; Rosa J Samuel; Subbaraya G Ramachandra; Dipankar Nandi; Nagalingam R Sundaresan
Journal:  J Biol Chem       Date:  2018-06-21       Impact factor: 5.157

Review 3.  Myxomatous mitral valve disease in dogs: does size matter?

Authors:  Heidi G Parker; Paul Kilroy-Glynn
Journal:  J Vet Cardiol       Date:  2012-02-20       Impact factor: 1.701

4.  Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease.

Authors:  Stephanie Klein; Ingo Nolte; José Luis Granados-Soler; Philipp Lietz; Maximiliane Sehn; Jonathan Friedemann Raue; Karl Rohn; Eva-Maria Packeiser; Jan-Peter Bach
Journal:  BMC Vet Res       Date:  2022-07-02       Impact factor: 2.792

5.  Telotristat ethyl reverses myxomatous changes in mice mitral valves.

Authors:  Xinmei Wang; Danielle Kuban-Johnston; Pablo Lapuerta; Carla M R Lacerda
Journal:  Front Cardiovasc Med       Date:  2022-08-04

6.  Contractile properties of the right atrial myofilaments in patients with myxomatous mitral valve degeneration.

Authors:  Constanze Bening; Uwe Mehlhorn; Lars Oliver Conzelmann; Nicole Stumpf; Anjuli Sikand; Christian-Friedrich Vahl
Journal:  BMC Cardiovasc Disord       Date:  2014-09-16       Impact factor: 2.298

Review 7.  Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human.

Authors:  Greg R Markby; Kim M Summers; Vicky E MacRae; Brendan M Corcoran
Journal:  Vet Sci       Date:  2017-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.